REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 31 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,541,000 | -14.7% | 1,462,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,806,000 | -27.6% | 1,462,000 | -45.0% | 0.00% | 0.0% |
| Q4 2022 | $2,494,000 | -10.3% | 2,660,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,780,000 | +1.2% | 2,660,000 | -15.5% | 0.00% | 0.0% |
| Q2 2022 | $2,747,000 | -11.9% | 3,148,000 | -5.5% | 0.00% | 0.0% |
| Q1 2022 | $3,118,000 | -12.0% | 3,332,000 | -17.7% | 0.00% | 0.0% |
| Q4 2021 | $3,544,000 | -37.5% | 4,047,000 | -17.9% | 0.00% | 0.0% |
| Q3 2021 | $5,669,000 | -1.5% | 4,932,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $5,754,000 | +5.2% | 4,932,000 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $5,471,000 | – | 4,882,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |